GRM4 and depressive symptom measurement: Further interesting studies on miR-1202, including molecular imaging studies, have shown that changes in miR-1202 levels during antidepressant treatment are correlated with changes in brain activity [52], and that genetic variants of the GRM4 gene at the binding site of miR-1202 are potentially associated with a heightened risk of developing depression.